Semaglutide to help reduce cannabis use disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests whether a medication called semaglutide (used for weight management) can help adults with cannabis use disorder cut down or stop using cannabis. Researchers want to see if it reduces cravings and use while also monitoring overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You use cannabis at least 16 days per month and want to reduce or quit
- You have a positive urine test for cannabis use in the past 28 days
- You are 18–70 years old with a BMI of at least 23 kg/m² (roughly 5'6" and 160+ lbs, depending on height)
- You do not have other substance use disorders (besides tobacco) or severe mental health conditions like schizophrenia or bipolar disorder in the past 5 years
- You have no history of suicide attempt, severe brain injury, stroke, diabetes, or serious heart disease
- You speak and understand Danish and can follow study procedures for several months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tirzepatide, a medicine used for type 2 diabetes and weight loss, can help people with severe cannabis use disorder cut down or quit. It may reduce cravings and other symptoms of withdrawal.
This study tests whether tirzepatide, a medicine used for diabetes and weight loss, can help reduce cannabis use in people with moderate to severe cannabis use disorder. If you qualify, you would take the medicine for a period and track your cannabis use.
This study tests whether a weekly injection of semaglutide (a medication used for weight loss and diabetes) can help reduce symptoms of depression in people who have major depressive disorder and are overweight or obese.
This study tests whether semaglutide, a medication used for weight management, can help reduce cocaine use in people with cocaine use disorder. You may qualify if you have a body mass index (BMI) of 25 or higher and recently used cocaine.
This trial tests if semaglutide (a medicine used for diabetes and weight loss) can help reduce methamphetamine use. If you qualify, you might get the study drug and support to help you cut back or stop using methamphetamine.
This study tests whether semaglutide (a medication used for weight management) can help people on buprenorphine or methadone reduce their opioid use. If it works, it could provide additional support during recovery.
Hear when a new Cannabis Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.